CAJ | 학술논문

目的：探讨血栓通对超早期中小量脑出血患者血肿扩大的影响。方法：将243例超早期中小量脑出血患者随机分为治疗组113例、对照组130例，对照组给予西医常规治疗，治疗组在西医常规治疗的基础上予静脉滴注标准剂量的血栓通针剂。2组患者均在出血后24小时、1周复查颅脑CT。比较2组出血量的变化。结果：治疗24小时后、治疗1周后2组血肿扩大率比较无明显差异（P＞0.05）。结论：血栓通与中小量脑出血患者发生血肿体积扩大无明显相关性。
목적：탐토혈전통대초조기중소량뇌출혈환자혈종확대적영향。방법：장243례초조기중소량뇌출혈환자수궤분위치료조113례、대조조130례，대조조급여서의상규치료，치료조재서의상규치료적기출상여정맥적주표준제량적혈전통침제。2조환자균재출혈후24소시、1주복사로뇌CT。비교2조출혈량적변화。결과：치료24소시후、치료1주후2조혈종확대솔비교무명현차이（P＞0.05）。결론：혈전통여중소량뇌출혈환자발생혈종체적확대무명현상관성。
Objective:To investigate the influence of XueShuanTong on hematoma enlargement of the patients suffering from cerebral hemorrhage with moderate amount of bleeding at super early stage. Method:All 243 patients were randomly divided into 113 cases of the treatment group and 130 cases of the control group. The control group received routine treatment of Western Medicine and the treatment group intravenous dripping of XueShuanTong. Cranial computed tomography of the patients in both groups were preformed in 24 hours after bleeding and in one week. The changes of bleeding amounts were compared between both groups. Result: The comparisons between both groups in hematoma enlargement rates showed insignificant difference after treating for 24 hours and one week (P>0.05). Conclusion:XueShuanTong shows no relevance to hematoma enlargement of the patients suffering from cerebral hemorrhage with moderate amount of bleeding.